VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,533,807 | -11.8% | 317,124 | -1.3% | 0.13% | -1.5% |
| Q2 2023 | $9,674,494 | -8.3% | 321,305 | -1.5% | 0.13% | -24.6% |
| Q1 2023 | $10,548,106 | +10.2% | 326,062 | -2.4% | 0.18% | -2.2% |
| Q4 2022 | $9,574,504 | +17.8% | 334,072 | -0.8% | 0.18% | +26.1% |
| Q3 2022 | $8,125,000 | -12.1% | 336,847 | -0.3% | 0.14% | -13.9% |
| Q2 2022 | $9,247,000 | -30.3% | 337,736 | -2.4% | 0.16% | +34.1% |
| Q1 2022 | $13,266,000 | +18.4% | 345,923 | -1.1% | 0.12% | +92.2% |
| Q4 2021 | $11,203,000 | +8.5% | 349,757 | -0.2% | 0.06% | +18.5% |
| Q3 2021 | $10,330,000 | -13.4% | 350,515 | -0.2% | 0.05% | -8.5% |
| Q2 2021 | $11,933,000 | +4.0% | 351,173 | -0.5% | 0.06% | -4.8% |
| Q1 2021 | $11,470,000 | -12.8% | 352,917 | -3.3% | 0.06% | -4.6% |
| Q4 2020 | $13,150,000 | -56.4% | 365,082 | -52.6% | 0.06% | -65.1% |
| Q3 2020 | $30,142,000 | +118.9% | 769,719 | +105.0% | 0.19% | +72.2% |
| Q2 2020 | $13,771,000 | +56.6% | 375,444 | -1.6% | 0.11% | +2.9% |
| Q1 2020 | $8,794,000 | -27.7% | 381,694 | -8.1% | 0.10% | -16.7% |
| Q4 2019 | $12,160,000 | +7.9% | 415,285 | -1.6% | 0.13% | -2.3% |
| Q3 2019 | $11,267,000 | +0.6% | 421,826 | -3.7% | 0.13% | +14.2% |
| Q2 2019 | $11,201,000 | +11.0% | 438,223 | -2.7% | 0.11% | +4.6% |
| Q1 2019 | $10,095,000 | -30.0% | 450,246 | -34.2% | 0.11% | -47.1% |
| Q4 2018 | $14,425,000 | +13.4% | 683,974 | -0.4% | 0.20% | +56.9% |
| Q3 2018 | $12,717,000 | -18.5% | 686,653 | -1.8% | 0.13% | -22.6% |
| Q2 2018 | $15,605,000 | +0.9% | 699,463 | -0.6% | 0.17% | -12.5% |
| Q1 2018 | $15,472,000 | +35.9% | 703,935 | +43.7% | 0.19% | +25.5% |
| Q4 2017 | $11,382,000 | -1.1% | 489,750 | -2.3% | 0.15% | -5.6% |
| Q3 2017 | $11,510,000 | +2.0% | 501,307 | -1.9% | 0.16% | -3.0% |
| Q2 2017 | $11,288,000 | -4.7% | 511,241 | -1.5% | 0.17% | -16.5% |
| Q1 2017 | $11,842,000 | +5.7% | 519,158 | -3.0% | 0.20% | -9.5% |
| Q4 2016 | $11,201,000 | -22.9% | 535,437 | -2.6% | 0.22% | -11.6% |
| Q3 2016 | $14,534,000 | -6.1% | 549,922 | -1.5% | 0.25% | -18.8% |
| Q2 2016 | $15,474,000 | – | 558,410 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |